Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · IEX Real-Time Price · USD
1.220
-0.070 (-5.43%)
Jul 22, 2024, 9:30 AM EDT - Market open

CNTB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Market Capitalization
686550296--
Market Cap Growth
-78.06%30.34%-83.17%---
Enterprise Value
54-53-10228-140-46
PE Ratio
--1.09-0.42-1.46--
PB Ratio
5.040.640.321.09--
P/FCF Ratio
-1.43-1.43-0.47-3.23--
P/OCF Ratio
-1.36-1.36-0.49-3.51--
EV/EBITDA Ratio
0.900.900.87-0.141.322.01
EV/EBIT Ratio
0.900.900.87-0.141.322.01
EV/FCF Ratio
1.181.180.96-0.315.613.71
Debt / Equity Ratio
0.000.000.000.000.000.00
Debt / EBITDA Ratio
-0.01-0.010.000.000.00-0.01
Debt / FCF Ratio
-0.01-0.010.000.00-0.01-0.01
Quick Ratio
4.894.899.7614.8926.9312.40
Current Ratio
4.994.999.9715.3027.8113.24
Interest Coverage
-2580.87-2580.87-5608.19-28856.14-268.35-3180.60
Return on Equity (ROE)
-46.00%-46.00%-55.00%-306.80%117.80%-
Return on Assets (ROA)
-39.70%-39.70%-50.80%-92.00%-106.90%-
Return on Capital (ROIC)
-61.15%-61.15%-75.55%-36.02%19.31%37.07%
Earnings Yield
-85.03%-91.62%-236.98%-68.32%--
FCF Yield
-8.90%-69.72%-212.57%-30.94%--
Buyback Yield / Dilution
4.25%4.15%0.11%-6.57%--
Total Shareholder Return
4.25%4.15%0.11%-6.57%--
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).